Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Population‐based discovery and Mendelian randomization analysis identify telmisartan as a candidate medicine for Alzheimer's disease in African Americans
Pengyue Zhang, Yuan Hou, Wanzhu Tu, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 5, pp. 1876-1887
Open Access | Times Cited: 18

Showing 18 citing articles:

Multi-target drugs for Alzheimer's disease
Bengisu Turgutalp, Çağhan Kızıl
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 7, pp. 628-638
Closed Access | Times Cited: 14
Development of Telmisartan Nanocrystal-Based Dissolving Microneedle for Brain Targeting via Trigeminal Pathway: A Potentially Promising Treatment for Alzheimer’s with an Improved Pharmacokinetic Profile
Aqilah Fidya Madani, Muhammad Ammar Syauqi, Jihan A. Permatasari, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 4, pp. 2582-2593
Closed Access | Times Cited: 5
Gastrodin ameliorates neuroinflammation in Alzheimer’s disease mice by inhibiting NF-κB signaling activation via PPARγ stimulation
Haoyuan Yin, Renjie Liu, Li Bie
Aging (2024) Vol. 16, Iss. 10, pp. 8657-8666
Open Access | Times Cited: 5
Alzheimer’s Disease: Exploring Pathophysiological Hypotheses and the Role of Machine Learning in Drug Discovery
Jose Dominguez-Gortaire, Alejandra Ruiz, Ana B. Porto-Pazos, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1004-1004
Open Access
Drug repurposing for Alzheimer’s disease and other neurodegenerative disorders
Jeffrey L. Cummings, Yadi Zhou, Alexandra Stone, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Clinical use of a fixed-dose combination of telmisartan and indapamide in hypertension. Expert Council resolution
А. О. Конради, Ф. Т. Агеев, А. S. Galyavich, et al.
Russian Journal of Cardiology (2025) Vol. 30, Iss. 1, pp. 6249-6249
Open Access
Telmisartan Alleviates Alzheimer’s Disease-Related Neuropathologies and Cognitive Impairments
Xinxin Fu, Bin Wei, Haiming Cao, et al.
Journal of Alzheimer s Disease (2023) Vol. 94, Iss. 3, pp. 919-933
Closed Access | Times Cited: 9
Sex-stratified genome-wide association and transcriptome-wide Mendelian randomization studies reveal drug targets of heart failure
Qianqian Yang, Qian Yang, Xueyan Wu, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 2, pp. 101382-101382
Open Access | Times Cited: 3
Therapeutic Implications of Renin–Angiotensin System Modulators in Alzheimer’s Dementia
Daniela Carmen Ababei, Veronica Bild, Ioana Macadan, et al.
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2290-2290
Open Access | Times Cited: 6
An Ecocriticism of One Selected IsiXhosa Folktale as Part of Oral Literature
Mlamli Diko
Journal of Language and Literature (2024) Vol. 24, Iss. 1, pp. 201-213
Open Access | Times Cited: 1
Ras, RhoA, and vascular pharmacology in neurodevelopment and aging
Ruth Nussinov, Hyunbum Jang, Feixiong Cheng
Neurochemistry International (2024) Vol. 181, pp. 105883-105883
Closed Access | Times Cited: 1
Disentangling in-vivo microstructural changes of white and gray matter in mild cognitive impairment and Alzheimer’s disease: a systematic review and meta-analysis
Shuchang Zhong, Jingjing Lou, Ke Ma, et al.
Brain Imaging and Behavior (2023) Vol. 17, Iss. 6, pp. 764-777
Closed Access | Times Cited: 4
Behavioral and Proteomic Studies Reveal Methylglyoxal Activate Pathways Associated with Alzheimer’s Disease
Gouri V. Patil, Shabda E Kulsange, Rubina Kazi, et al.
ACS Pharmacology & Translational Science (2022) Vol. 6, Iss. 1, pp. 65-75
Closed Access | Times Cited: 5
Investigating the Impact of Selective Modulators on the Renin–Angiotensin–Aldosterone System: Unraveling Their Off-Target Perturbations of Transmembrane Ionic Currents
Te‐Ling Lu, Sheng‐Nan Wu
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14007-14007
Open Access | Times Cited: 2
Perturbations of Telmisartan Alone and in Combination with Ranolazineor Dapagliflozin on the Amplitude and Gating of Voltage-gated Na+ Current in Neuroblastoma Neuronal Cells
Yi-Jung Chen, Chien-Ching Lee, Edmund Cheung So
Journal of physiological investigation. (2024) Vol. 67, Iss. 3, pp. 103-106
Open Access
Alzheimer's disease: A role of biomarkers in early diagnosis and evidences from African ethnomedicinal knowledge
Acharya Balkrishna, Sonam Verma, Sumit Kumar Singh, et al.
European Journal of Neuroscience (2023) Vol. 58, Iss. 1, pp. 2406-2425
Open Access
Reply to: Comparator choices in pharmacoepidemiology studies of Alzheimer’s disease
Pengyue Zhang, Yuan Hou, Chien‐Wei Chiang, et al.
Nature Aging (2023) Vol. 3, Iss. 7, pp. 793-795
Closed Access
RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one
Rodolfo Pedro Rothlin, Facundo Pelorosso, Mariano Duarte, et al.
Revista Portuguesa de Cardiologia (2023) Vol. 43, Iss. 4, pp. 219-220
Open Access
Page 1

Scroll to top